ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1728

Interferon Gamma (IFN-γ) Subpopulations in Skin Homing T Cells of Localized Scleroderma

Claudia Macaubas1, Emily Mirizio2, Kaila Schollaert-Fitch3, Elizabeth D. Mellins4 and Kathryn S. Torok3, 1Department of Pediatrics, Program in Immunology, Stanford University Med Ctr, Stanford, CA, 2Pediatric Rheumatology, Univ of Pittsburgh Med Ctr, Pittsburgh, PA, 3Pediatric Rheumatology, University of Pittsburgh Med Ctr, Pittsburgh, PA, 4Dept of Pediatrics CCSR, Stanford University Med Ctr, Stanford, CA

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Biomarkers, Pediatric rheumatology, scleroderma and skin fibrosis, T cells

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Pathogenesis, Animal Models and Genetics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Localized scleroderma (LS) has both inflammatory and fibrotic components contributing to its effect on the skin and underlying tissue.   The understanding of the pathophysiology driving this process is limited, though there is evidence supporting T cell involvement in both systemic sclerosis (SSc), its related disease, and LS.  Recent studies in SSc have focused on skin homing T cells in the circulating peripheral blood which may be directly contributing to disease progression and skin inflammation with subsequent fibrosis (1). We aim to study this same concept in LS and investigate skin homing cells that may contribute to skin inflammation and reflect activity at lesion sites.

Methods:

PBMCs were isolated from 10 pediatric LS subjects with paired active/inactive blood specimens (20 samples total), and were analyzed at rest and after PMA/ionomycin stimulation. Flow cytometry was performed to characterize T cells using antibodies for T cell subsets (CD3, CD4, CD8, CD28), T memory cells (CD45RO), T trafficking and adhesion (CXCR3, CCR4, CCR6, CD62L), and skin homing cells (CCR10 and CLA). Selected intracellular TH1 and TH2 cytokines (IFN-γ, TNF-α, and IL-13) were also measured. Cell populations were compared between LS active and inactive disease states using paired Wilcoxon Signed-Ranks Test.

Results:

The proportion of CD4+ (TH) and CD8+ (TC) T cells among total PBMC were not significantly different between active and inactive disease states. However, there was a significant increase in the proportion of skin homing CCR10+ TC (Fig.1A) in samples collected during active disease. In addition, both CCR10+ TC and CCR10+ TH cells produced inflammatory cytokine populations, IFN-γ, that were significantly increased in the active disease state compared to the inactive disease state (Fig 1B).

Conclusion:

This is one of the first studies to examine circulating cell immunophenotypes in pediatric-onset localized scleroderma, with emphasis on examining the association of T skin homing cell subtypes with disease activity. These findings suggest increased skin homing (CCR10+) of inflammatory cytokine producing subpopulations of TC and TH cells in active disease (Fig 1). In adult SSc, IL-13+, and not IFN-γ+, CD8+CCR10+ cells appear to be the skin homing cell type that propagates disease (1), emphasizing possible biological differences in scleroderma phenotypes; more inflammatory, TH1/TC1 phenotype in LS and the more fibrotic, TH2/TC2 phenotype, in SSc. Determining active disease status in patients with scleroderma may allow targeting of key immune components to prevent damage and disfigurement.

References:

(1)  Li G, Larregina AT, Domsic RT, Stolz DB, Medsger TA, Jr., Lafyatis R, Fuschiotti P. Skin-Resident Effector Memory CD8+CD28- T Cells Exhibit a Profibrotic Phenotype in Patients with Systemic Sclerosis. J Invest Dermatol. 2017;137(5):1042-50.


Disclosure: C. Macaubas, None; E. Mirizio, None; K. Schollaert-Fitch, None; E. D. Mellins, None; K. S. Torok, None.

To cite this abstract in AMA style:

Macaubas C, Mirizio E, Schollaert-Fitch K, Mellins ED, Torok KS. Interferon Gamma (IFN-γ) Subpopulations in Skin Homing T Cells of Localized Scleroderma [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/interferon-gamma-ifn-%ce%b3-subpopulations-in-skin-homing-t-cells-of-localized-scleroderma/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/interferon-gamma-ifn-%ce%b3-subpopulations-in-skin-homing-t-cells-of-localized-scleroderma/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology